Health Advisory: COVID-19 Updates for Providers

stethoscope sitting on laptop keyboard

Actions Requested

COVID-19 Situation Update

As of February 23, Kitsap County has had 38,329 cases of COVID-19 and 316 deaths from COVID-19. Our seven-day case rate dropped to 189.6 per 100,000 showing a consistently decreasing trend over the past week. Rates across sub-county areas range from 76 to 228 per 100,000 residents.

During the week ending February 19, we had 52 new COVID-19 hospitalizations among Kitsap residents. In the past 180 days, unvaccinated people ages 12-59 were six times more likely to be hospitalized for COVID-19 than those fully vaccinated; nearly four times more likely for those age 60 and older.

To date, 31 Kitsap resident COVID-19 related deaths have been reported for January and 12 for February. In the past 180 days, unvaccinated people ages 30-69 were 22 times more likely to die from COVID-19 than those fully vaccinated; four times more likely for those age 70 and older.

The chart below shows our most recent case rate, vaccination rate and COVID-19 cases trend over time:

COVID-19 vaccine

As of February 23, 76.8% of Kitsap County residents have initiated vaccination. Nearly 89,000 (32.7%) Kitsap residents have received an additional or booster vaccine dose. As of February 19, only 35% of children aged 5-11 have initiated vaccination. All Kitsap subcounty areas have at least 70% vaccination initiation rates among those age 12 and older. Differences in vaccination initiation rates persist across race/ethnicity groups, the gap between highest and lowest rate is 42%.

In people 18–39 years old, myocarditis occurs in an estimated 23–33 per million people following a second dose of mRNA COVID-19 vaccine. Nearly all cases are transient and can be treated on an outpatient basis. Recent research shows increasing the interval between first and second doses of mRNA COVID-19 vaccine from 3–4 weeks to 8 weeks can reduce the risk of myocarditis by over half while also substantially improving efficacy.

CDC guidance allows clinicians to decide when the benefits of the extended interval exceed the increased risk of COVID‑19 infection. Regardless of the interval between first and second doses, a booster dose should be delivered no sooner than 5 months after the second dose. These changes do not affect people with compromised immune systems or people over 65 years old, as the risk of COVID-19 infection outweighs the benefit of reduced myocarditis incidence.


COVID-19 testing

COVID-19 prevention patient education

Share with patients:

Contacting the Health District

  • Call (360) 728-2235 and leave a message. Includes reporting notifiable conditions 24 hours a day, 7 days a week. Leave the patient’s name, date of birth and disease.
  • Fax (360) 813-1379.

Additional Resources